You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGFR wild-type

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Trial (Savolitinib, Durvalumab)

Recruiting
  • Lung Cancer
  • Beijing, China
  • +2 more
Jan 11, 2023

Efficacy Trial in Suzhou (TAB008, Bevacizumab)

Completed
  • Efficacy
  • Suzhou, Jiangsu, China
    TOT
Jun 16, 2022

Nonsquamous Nonsmall Cell Tumor of Lung Trial in Taipei (BLEX 404)

Not yet recruiting
  • Nonsquamous Nonsmall Cell Neoplasm of Lung
  • BLEX 404
  • Taipei, Taiwan
    Taipei Veteran General Hospital
Feb 28, 2023

NSCLC Trial in Guangzhou (SBRT, Tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 17, 2022

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Lung Adenocarcinoma Trial in ZhengZhou (CIK, chemo)

Terminated
  • Lung Adenocarcinoma
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
May 10, 2021

NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Fayetteville, Arkansas
  • +7 more
Jan 21, 2022

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

Circulating Tumour DNA Testing in Assessing for Alterations of

Recruiting
  • Colorectal Cancer
    • Singapore, Singapore
      National University Hospital
    Sep 28, 2021

    NSCLC (NSCLC) Trial in China (Capmatinib)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • Xiamen, Fujian, China
    • +18 more
    Jan 27, 2023

    Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

    Recruiting
    • Nonsquamous Non-Small Cell Lung Cancer
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Nov 5, 2021

    Metastatic Colorectal Cancer Trial in Worldwide (Futuximab/modotuximab, Trifluridine/Tipiracil)

    Recruiting
    • Metastatic Colorectal Cancer
    • Ann Arbor, Michigan
    • +10 more
    Dec 2, 2022

    NSCLC Trial in Worldwide (INC280 (capmatinib))

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • INC280 (capmatinib)
    • Long Beach, California
    • +95 more
    Dec 29, 2022

    Advanced Colorectal Cancer Trial in Seoul (Cetuximab, irinotecan)

    Completed
    • Advanced Colorectal Cancer
    • Cetuximab, irinotecan
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 17, 2021

    Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

    Recruiting
    • Nonsquamous Non-Small Cell Lung Cancer
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Nov 5, 2021

    Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

    Not yet recruiting
    • Colorectal Cancer
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
    Jan 30, 2023

    Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Microsatellite

    Recruiting
    • Advanced Microsatellite Stable Colorectal Carcinoma
    • +5 more
    • Atlanta, Georgia
    • +2 more
    Oct 29, 2021

    Advanced Colorectal Cancer Trial in Cyprus, Greece (Panitumumab)

    Terminated
    • Advanced Colorectal Cancer
    • Strovolos, Nicosia, Cyprus
    • +7 more
    Jun 2, 2021

    Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Cetuximab and irinotecan
    • (no location specified)
    Jul 26, 2023

    Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)

    Recruiting
    • Polyneuropathy
    • Amyloidosis
    • ECG + echocardiography
    • Answering questionnaires
    • Jette, Belgium Capital City, Belgium
      UZ Brussel
    Jul 14, 2023

    Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

    Not yet recruiting
    • Colorectal Cancer
    • (no location specified)
    Mar 23, 2023

    RAS Wild-type mCRC Resistance to Anti-EGFR-antibody

    Completed
    • Colorectal Cancer
      • Guanzhou, Guangdong, China
        Medical Oncology,Sun Yat-sen University Cancer Center
      Jul 6, 2020

      Colo-rectal Cancer Trial (biological, drug, procedure)

      Not yet recruiting
      • Colo-rectal Cancer
      • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
      • +8 more
      • (no location specified)
      Aug 28, 2023

      Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

      Not yet recruiting
      • Ovarian Cancer
      • +4 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Cetntre
      Sep 25, 2023

      Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

      Not yet recruiting
      • Colorectal Cancer
      • Liver Metastases
      • mFOLFOX6 + Cetuximab
      • mFOLFOX 6
      • Shanghai, China
        Zhongshan hosptial, Fudan University
      Jul 14, 2023